|
MNAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.28869999963477E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.14550000005232E-06 |
| Normal-vs-Stage2 |
1.235510E-03 |
| Normal-vs-Stage3 |
1.63062999999353E-05 |
| Normal-vs-Stage4 |
2.12249999999026E-05 |
| Stage1-vs-Stage2 |
7.649400E-01 |
| Stage1-vs-Stage3 |
5.457600E-01 |
| Stage1-vs-Stage4 |
4.495000E-01 |
| Stage2-vs-Stage3 |
4.928400E-01 |
| Stage2-vs-Stage4 |
3.700600E-01 |
| Stage3-vs-Stage4 |
7.889600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.46030000045283E-07 |
| Normal-vs-AfricanAmerican |
4.657600E-01 |
| Normal-vs-Asian |
1.233460E-04 |
| Caucasian-vs-AfricanAmerican |
7.142500E-03 |
| Caucasian-vs-Asian |
9.953200E-01 |
| AfricanAmerican-vs-Asian |
1.461540E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92470000004441E-06 |
| Normal-vs-Female |
2.43879999994867E-06 |
| Male-vs-Female |
5.258600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62434999999572E-05 |
| Normal-vs-Age(41-60Yrs) |
1.87809999996347E-06 |
| Normal-vs-Age(61-80Yrs) |
4.596000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.132000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.362000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.857600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.230600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.474200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.468000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.818000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.714370E-02 |
| Classical-VS-Follicular |
8.643400E-01 |
| Classical-VS-Other |
8.682400E-01 |
| Classical-VS-Normal |
1.60819999999173E-05 |
| Tall-VS-Follicular |
2.896500E-02 |
| Tall-VS-Other |
1.296550E-01 |
| Tall-VS-Normal |
1.84480000053888E-07 |
| Follicular-VS-Other |
8.500800E-01 |
| Follicular-VS-Normal |
7.427800E-04 |
| Other-VS-Normal |
1.349770E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.23359999957418E-07 |
| Normal-vs-N1 |
1.24800000000924E-06 |
| N0-vs-N1 |
4.552000E-01 |
|
|
